Innovating Works

PROTEODESIGN

Activa
SPLITVAC: Harnessing the innate and adaptive immune system with targeted neoantigen based cancer vaccines PROTEODESIGN tramitó un H2020: H2020-MSCA-IF-2018 Immunotherapy for cancer has recently shown great clinical potential. However, only small percentages of patients do benefit from these ther...
2019-04-05 - 2021-05-19 | Financiado
INPACT: Innovative peptides against cancer and pathogenic bacteria with advances in science biopharmaceuti... INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES tramitó un H2020: H2020-MSCA-RISE-2014 INPACT aims at the pre-clinical development of innovative drugs and drug formulations against selected cancers (eg prostate cancer) and path...
2014-11-19 - 2019-01-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.